Evidence map›Paper›PMID 39809967›Full record

ArticleJournal of applied genetics2025

Novel and recurrent genetic variants associated with male and female infertility.

Katarzyna K Jankowska, Anna Kutkowska-Kazmierczak, Klaudia Ślusarczyk, Alicja Domaszewicz, Katarzyna Duk, Jan Karol Wolski, Katarzyna Kozioł, Justyna Sawicka, Jakub Klapecki, Piotr Laudański and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of applied genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The role of satellite DNA-enriched heterochromatic variants in reproductive disorders: Insights from standardized cytogenetic analysis.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Katarzyna K JankowskaDepartment of Endocrinology, Center of Postgraduate Medical Education, Bielanski Hospital, Warsaw, Poland.
Anna Kutkowska-KazmierczakDepartment of Medical Genetics, Institute of Mother and Child, Warsaw, Poland.
Klaudia ŚlusarczykDepartment of Medical Genetics, Institute of Mother and Child, Warsaw, Poland.
Alicja DomaszewiczDepartment of Medical Genetics, Institute of Mother and Child, Warsaw, Poland.
Katarzyna DukDepartment of Medical Genetics, Institute of Mother and Child, Warsaw, Poland.
Jan Karol WolskinOvum Fertility Clinic, Warsaw, Poland.
Katarzyna KoziołnOvum Fertility Clinic, Warsaw, Poland.
Justyna SawickaDepartment of Medical Genetics, Institute of Mother and Child, Warsaw, Poland.
Jakub KlapeckiDepartment of Medical Genetics, Institute of Mother and Child, Warsaw, Poland.
Piotr LaudańskiDepartment of Obstetrics, Gynecology and Gynecological Oncology, Medical University of Warsaw, Warsaw, Poland.
Katarzyna Wertheim-TysarowskaDepartment of Medical Genetics, Institute of Mother and Child, Warsaw, Poland.
Agnieszka Magdalena RygielDepartment of Medical Genetics, Institute of Mother and Child, Warsaw, Poland. agnieszka.rygiel@imid.med.pl.ORCID http://orcid.org/0000-0002-3838-2900

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, the knowledge of the genetic basis of fertility disorders has expanded enormously, mainly thanks to the use of next-generation sequencing (NGS). However, the genetic cause of infertility, in the majority of patients, is still undefined. The aim was to identify novel and recurrent pathogenic/likely pathogenic variants in patients with isolated infertility or puberty delay using a targeted NGS technique. We have enrolled 41 patients (36 males and 5 females) with infertility problems or delayed puberty. We included the patients with hypogonadotropic hypogonadism (n = 12), hypergonadotropic hypogonadism (n = 15), abnormal sperm parameters (n = 10), androgen insensitivity syndrome (n = 3) and 46,XY gonadal dysgenesis (n = 1). Genetic tests were performed using targeted NGS panel of 35 genes implicated in fertility. Pathogenic or likely pathogenic variants potentially explaining the clinical phenotype were identified in 12 of 41 patients (29%). These included 9 of 12 patients (75%) with hypogonadotropic hypogonadism, 2 of 3 patients (66%) with androgen insensitivity syndrome, and the single patient with 46,XY gonadal dysgenesis. Among the 18 identified variants, 4 were novel (FGF8:p.Ala147Thr; SEMA3A:p.Arg544Cys; FGFR1:p.Thr141IlefsTer10; NSMF: p.Tyr242Cys), while 14 were recurrent. Our study expands the knowledge of the genetic basis of the infertility disorders and highlights the importance of genetic testing for proper diagnosis making and genetic counselling.

Indexed as

Infertility, FemaleInfertility, MaleAdolescentAdultAndrogen-Insensitivity SyndromeFemaleHigh-Throughput Nucleotide SequencingHumansHypogonadismMaleMutationPhenotypePuberty, DelayedAndrogen insensitivity syndromeGenetic diagnosticsGenetic variantsHuman infertilityHypergonadotropic hypogonadismHypogonadotropic hypogonadism

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.